−23.6
BioLineRx Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−26.2
FY23:
−22.6
FY24:
−43.9
FY25:
−8.07
Change from FY21 to FY25
millions USD
FY21:
−38.2
FY22:
4.01
FY23:
1.44
FY24:
29.4
FY25:
−8.55
Change from FY21 to FY25
millions USD
FY21:
57.7
FY22:
20.4
FY23:
15.1
FY24:
20.7
FY25:
8.88
millions USD
FY21:
−4.05
FY22:
−1.80
FY23:
−6.11
FY24:
6.16
FY25:
−7.74
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.7
FY22:
−26.4
FY23:
−22.7
FY24:
−43.9
FY25:
−8.10
All amounts in millions USD